Queen Mary Hospital
Hong Kong, China
NCT Number: NCT00404794
This is a prospective randomized open-label pilot study to compare mycophenolate mofetil in combination with corticosteroid treatment and tacrolimus in combination with corticosteroid treatment in membranous lupus nephritis. The change in urine protein excretion will be the primary outcome studied. The study duration will be 24 months for each patient.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 3
Hong Kong, China
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Hospital Authority, Hong Kong
Other Gov
A Prospective Randomized Open-label Study to Compare Mycophenolate Mofetil and A Prospective Randomized Open-label Study to Compare Mycophenolate Mofetil and Corticosteroid With Tacrolimus and Corticosteroid as Immunosuppressive Treatment for Lupus Membranous Nephritis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03453619
Autoimmune Diseases, C3 Glomerulonephritis
Stanford, California, United States
View Trial DetailsNCT07721363
Autoimmune Diseases, Connective Tissue Diseases
Paris, France
View Trial DetailsNCT05732402
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
Phoenix, Arizona, United States
View Trial DetailsNCT03929887
Autoimmune Diseases, Connective Tissue Diseases
Chuncheon, South Korea
View Trial Details